NIH Schedules Secret Meetings to Review Future Grants
Published Date: 6/2/2026
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications. These meetings protect sensitive info like personal details and trade secrets, so they’re not open to the public. Researchers applying for funding and the scientific community should note these dates as they impact grant decisions and future research funding.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
Impact on grant applicants and researchers
Researchers who applied for NIH grants should note that their applications will be reviewed during closed virtual meetings on June 24-25, 2026 and June 30, 2026, and that discussions will be conducted to evaluate and decide on grant applications. The closures are intended to protect confidential trade secrets and personal information under 5 U.S.C. 552b(c)(4) and 552b(c)(6), which can affect grant decisions and future research funding.
Closed NIH grant review meetings
The NIH Center for Scientific Review will hold several closed virtual meetings on June 24-25, 2026 and June 30, 2026 to review and evaluate grant applications. These meetings are closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect trade secrets, commercial property, and personal information.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14666 — National Institute of Neurological Disorders and Stroke; Notice of Meeting
The National Institute of Neurological Disorders and Stroke is hosting a free, virtual meeting on August 24, 2026, to talk about Parkinson’s disease research, care, and services. This meeting affects people with Parkinson’s, their families, and organizations working on the disease, as it will share updates and plan a federal list of Parkinson’s programs. Public comments are welcome until August 10, giving everyone a chance to join the conversation and help shape future efforts.
2026-14347 — Government Owned Invention Available for License: Method of Manufacturing Papilloma Infiltrating Lymphocyte (PIL) Cell Therapy Products as a Treatment for Patients With Chronic Viral Infection(s)
The National Cancer Institute has created a new way to make special immune cells called PILs that can fight chronic HPV infections causing painful growths in the throat and genital areas. This new cell therapy could reduce the need for repeated surgeries, improving patients’ lives and cutting healthcare costs. Researchers are now looking for partners to help develop and license this promising treatment soon.
2026-14346 — Government Owned Invention Available for License: Selective Expansion of Engineered TCR-T Cells for Use in Adoptive Cell Immunotherapy
The National Cancer Institute has invented a cool new way to grow special immune cells called TCR-T cells that can better fight cancer. This method helps companies make more powerful, targeted cell therapies by boosting the right cells and cutting out the extras. If you’re in biotech or cancer treatment, this is your chance to license a game-changing tool that could speed up cancer cures and bring new treatments to patients faster.
2026-14242 — National Institute on Minority Health and Health Disparities; Notice of Partially Closed Meeting
The National Institute on Minority Health and Health Disparities is holding a virtual meeting on August 31, 2026, to discuss important health topics and review grant applications. The first part of the meeting is open to the public and will be streamed online, while the last hour is closed to protect private info and trade secrets. This meeting affects researchers and communities focused on minority health and could influence future funding decisions.
2026-14133 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering new, powerful antibodies for licensing that help the immune system fight cancer better by releasing its natural brakes. This opportunity is perfect for companies ready to bring cutting-edge cancer treatments to market faster, with some international patent options available. Interested parties should act soon to explore this exciting tech and start making a difference—and money!
2026-14003 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important research grant applications. These meetings keep sensitive info private, protecting ideas and personal details. Scientists applying for grants and the research community will feel the impact as funding decisions get made on time.
Previous / Next Documents
Previous: 2026-10955 — LibreMax Asset-Backed Income Fund, et al.
LibreMax and its partners want permission to team up and invest together in the same companies, which usually isn’t allowed. This change affects certain investment funds and could help them work smarter and grow money more efficiently. If you want to speak up, you have until June 22, 2026, to ask for a hearing before the SEC decides.
Next: 2026-10957 — Agency Information Collection Activities; Proposed Collection; Comment Request; Extension: Rule 15c1-7
The SEC is asking for comments on keeping a rule that makes broker-dealers record every trade they make on customer accounts they control. About 325 broker-dealers handle around 400,000 trades a year, spending about 5 minutes each to log details like customer name, security info, and time. This helps stop fraud and keeps trading fair, with an estimated total yearly time cost of 33,333 hours across the industry.